Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel: Clinical implications

Anesthesiology

Volumn 84, Issue 6, 1996, Pages 1368-1379

  Nelson, Thomas E ^a   Lin, Marina ^a   Zapata Sudo, Gisele ^b   Sudo, Roberto Takashi ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Complications: malignant hyperthermia; Ions: calcium channels; Muscle: skeletal; Pharmacology: dantrolene; Receptors: ryanodine

Indexed keywords

CALCIUM ION; DANTROLENE; RYANODINE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; INTRACELLULAR TRANSPORT; MALIGNANT HYPERTHERMIA; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SWINE; TRANSPORT KINETICS;

ANIMALS; CALCIUM CHANNELS; DANTROLENE; DOGS; HUMANS; MALIGNANT HYPERTHERMIA; MUSCLE PROTEINS; MUSCLE RELAXANTS, CENTRAL; MUSCLE, SKELETAL; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SWINE;

EID: 0029944140     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199606000-00013     Document Type: Article

References (27)

1. Ward A, Chaffman MO, Sorkin EM: Dantrolene: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs 1986; 32:130-68
2. Flewellen EH, Nelson TE, Jones WP, Arens JF, Wagner DL: Dantrolene dose response in awake man: Implications for management of malignant hyperthermia. ANESTHESIOLOGY 1983; 59: 275-80
3. Van Winkle WB: Calcium release from skeletal muscle sarcoplasmic reticulum. Site of action of dantrolene sodium. Science 1976; 193:1130-1
4. Nelson TE: Dantrolene does not block calcium pulse-induced calcium release from a putative calcium channel in sarcoplasmic reticulum from malignant hyperthermia and normal pig muscle. FEBS Lett 1984; 167:123-30
5. 2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: The effects of halothane and dantrolene. FEBS Lett 1983; 161:103-7
6. Dehpour AR, Mofakham S, Mahmoudian M: In vitro binding of dantrolene to sarcoplasmic reticulum of rabbit skeletal muscle. Biochem Pharmacol 1982; 31:965-8
7. Sengupta C, Meyer UA, Carafoli E: Binding of dantrolene sodium to muscle intracellular membranes. FEBS Lett 1980; 117: 37-8
8. 3H]dantrolene binding to pig skeletal muscle membranes (abstract). Anesth Analg 1994; 78:S333
9. Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, O'Brien PJ, MacLennan DH: Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991; 253:448-51
10. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Worton RG: Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990; 343:559-61
11. McCarthy TV, Healy JM, Heffron JJ, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, Johnson K: Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 1990; 343:562-4
12. Gillard EF, Otsu K, Fujii J, Duff C, de Leon S, Khana VK, Britt BA, Worton RG, MacLennan DH: Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics 1992; 13:1247-54
13. Hogan K, Couch F, Powers PA, Gregg RG: A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia. Anesth Analg 1992; 75:441-8
14. Nelson TE: Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. J Clin Invest 1983; 72:862-70
15. Nelson TE, Flewellen EH, Gloyna DF: Spectrum of susceptibility to malignant hyperthermia - diagnostic dilemma. Anesth Analg 1983; 62:545-52
16. Nelson TE: Halothane effects on human malignant hyperthermia skeletal muscle single calcium-release channels in planar lipid bilayers. ANESTHESIOLOGY 1992; 76:588-95
17. Larach MG: Standardization of the caffeine halothane muscle contracture test: North American Malignant Hyperthermia Group (review). Anesth Analg 1989; 69:511-5
18. Wood DS, Zollman J, Reuben JP, Brandt PW: Human skeletal muscle: Properties of the "chemically skinned" fiber. Science 1975; 187:1075-6
19. Fabiato A: Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Meth Enzymol 1988; 157:378-417
20. Fabiato A, Fabiato F: Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris) 1979; 75:463-505
21. Orentlicher M, Brandt PW, Reuben JP: Regulation of tension in skinned muscle fibers: Effect of high concentrations of Mg-ATP. Am J Physiol 1977; 233:C127-34
22. Nelson TE, Lin M: Abnormal function of porcine malignant hyperthermia calcium release channel in the absence and presence of halothane. Cell Physiol Biochem 1995; 5:10-22
23. Nelson TE, Lin M: Dantrolene activates, then blocks the ryanodine-sensitive calcium release channel in a planar lipid bilayer (abstract). Biophys J 1993; 64:A380
24. Lai FA, Erickson HP, Rousseau E, Liu QY, Meissner G: Purification and reconstitution of the calcium release channel from skeletal muscle. Nature 1988; 331:315-9
25. Nelson TE: Ryanodine: Antithetical calcium channel effects in skeletal muscle sarcoplasmic reticulum. J Pharmacol Exp Ther 1987; 242:56-61
26. Wagenknecth T, Berkowitz J, Grassucci R, Timerman AP, Fleischer S: Localization of calmodulin binding sites on the ryanodine receptor from skeletal muscle by electron microscopy. Biophys J 1994; 67:2286-95
27. 2+ release channel (ryanodine receptor). Biophys J 1995; 69:106-19